Articles |
From the Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee.
| Abstract |
|---|
|
|
|---|
antibody (100 nmol/L) in the pipette solution
completely blocked the activation of the KCa channels
induced by 11,12-EET. An anti-Gß
or anti-Gi
antibody was without effect. We conclude that 11,12-EET
activates the KCa channels by a
GS
-mediated mechanism. This mechanism contributes to the
effects of EETs as endothelium-derived hyperpolarizing
factors to hyperpolarize and relax arterial smooth muscle.
Key Words: endothelium-derived hyperpolarizing factor patch clamp K+ channel eicosanoid G protein
| Introduction |
|---|
|
|
|---|
The mechanism by which EETs dilate coronary arteries and hyperpolarize vascular smooth muscle remains unknown. Recent studies have indicated that EETs activate a KCa channel in vascular smooth muscle cells.8 10 14 These results further support the hypothesis that EETs serve as EDHFs, since the KCa channels are thought to mediate the effect of EDHF.18 19 The purpose of the present study was to examine the effect of 11,12-EET on the activity of large-conductance KCa channels in vascular smooth muscle cells isolated from small bovine coronary arteries and to determine the mechanism by which 11,12-EET activates these channels.
| Materials and Methods |
|---|
|
|
|---|
Current Recordings
Single-channel K+ currents were recorded using
the patch-clamp technique as described by Hamill et al.20
Cell-attached, inside-out, and outside-out configurations were used to
identify the KCa channels and to determine the effect of
11,12-EET on the K+ currents in vascular smooth muscle
cells. Patch pipettes were made from borosilicate glass capillaries
that were pulled with a two-stage micropipette puller (PC-87, Sutter)
and heat-polished with a microforge (MF-90, Narishige). The pipettes
had tip resistances of 8 to 10 M
for single-channel
recordings when filled with 145 mmol/L KCl solution.
Smooth muscle cells were placed in a 1-mL perfusion chamber mounted on
the stage of a Nikon inverted microscope. After the tip of the pipette
was positioned on a cell, a high-resistance seal (5 to 15 G
) was
formed between the pipette tip and the cell membrane by applying a
light suction. The activity of K+ channels in the membrane
spanning the pipette tip was recorded. These measurements
represented the cell-attached mode. Inside-out membrane
patches were excised by lifting the pipette membrane complex to the
air/solution interface. Outside-out membrane patches were obtained by
withdrawing the pipette tip from the cell after establishment of the
whole-cell configuration, in which the membrane within the pipette was
disrupted by a large pulse of suction.
An EPC-7 patch-clamp amplifier (List Biological Laboratories, Inc) was
used to record single-channel currents. The amplifier output
signals were filtered at 1 KHz with an eight-pole Bessel filter
(Frequency Devices Inc). Currents were digitized at a sampling rate of
3 kHz and stored on the hard disk of a Gateway 486 DS66 computer for
off-line analysis. Data acquisition and analysis were
performed with pClamp software (version 5.7.1, Axon Instruments).
Average channel activity (NPo) in patches was determined
from recordings of several minutes by the following:
![]() |
Solutions
For single-channel recordings in the cell-attached mode,
the bath solution contained (mmol/L) KCl 145, CaCl2 1.8,
MgCl2 1.1, glucose 10, and HEPES 5 (pH 7.4), and the
pipette solution contained (mmol/L) KCl 145, CaCl2 1.8,
MgCl2 1.1, and HEPES 5 (pH 7.4). For single-channel
recordings using the inside-out excised membrane patch, the
bath solution contained (mmol/L) KCl 145, MgCl2 1.1, HEPES
10, and EGTA 2, along with 300 nmol/L ionized Ca2+ (pH
7.2). To determine the sensitivity of the channels to cytosolic
Ca2+, the concentration of ionized Ca2+ in the
bath solution was varied from 10-7 to
10-6 and then to 10-5
mol/L. Ca2+ concentration was estimated by a computer
program21 and was confirmed by measuring the free
Ca2+ concentration in the solution using fura 2 (Molecular
Probes Co) with a dual-wavelength spectrofluorometer (Perkin-Elmer).
The pipette solution contained (mmol/L) KCl 145, CaCl2 1.8,
MgCl2 1.1, and HEPES 10 (pH 7.4). For single-channel
recordings in the outside-out configuration, the bath solution
contained (mmol/L) KCl 145, CaCl2 1.8, MgCl2
1.1, glucose 10, and HEPES 10 (pH 7.4), and the pipette solution
contained (mmol/L) KCl 145, MgCl2 1.1, HEPES 10, and EGTA
2, along with 100 nmol/L ionized Ca2+ (pH 7.2). All
patch-clamp experiments were performed at room temperature,
20°C.
Identification of the KCa Channel in Small Bovine
Coronary Arteries
To establish current-voltage relations of the KCa
channel, inside-out patches were exposed to symmetrical KCl (145
mmol/L) solutions, and single-channel currents were recorded while
membrane potential was varied from -60 to +60 mV in steps of 20 mV.
K+ selectivity of the single-channel current was determined
by reducing K+ concentration in the pipette solution to
5.4 mmol/L (n=5). By changing the concentration of ionized
Ca2+ from 10-7 to
10-5 mol/L on the cytosolic side of inside-out
patches, the sensitivity of this KCa channel to
intracellular Ca2+ concentration was examined (n=8). The
effect of TEA (Sigma) (n=4) and IBX (Research Biochemicals Inc) (n=5)
on single K+ channels was examined using outside-out
excised membrane patches. TEA was added to bath solution at
concentrations of 0.1, 0.3, and 1 mmol/L. IBX was added to bath
solution at a concentration of 100 nmol/L.
Patch-Clamp Studies on the Effect of 11,12-EET
In cell-attached patches, symmetrical KCl (145 mmol/L)
solutions were used to null the membrane potential of the single smooth
muscle cell to near 0 mV. A 3-minute control recording at a
membrane potential of +40 mV was obtained after a tight seal was
established. Then the bath solution was rapidly changed by flushing the
perfusion chamber with 10 mL of the same solution containing 11,12-EET
(1, 10, or 100 nmol/L, n=7), 12-HETE (10 or 100 nmol/L, n=5), or
20-HETE (10 or 100 nmol/L, n=6), and a series of 3-minute
recordings was obtained. To examine the interaction of cholera
toxin and 11,12-EET on the activity of the KCa channel, 100
ng/mL cholera toxin was included in the pipette solution (n=8).
The excised-patch modes were used to further determine the mechanisms for the effect of 11,12-EET on the activity of the KCa channels. After inside-out patches were established, a 3-minute control recording was obtained at a membrane potential of +40 mV. Then the bath solution was rapidly changed by flushing the perfusion chamber with 5 to 10 mL of the same solution containing 1, 10, or 100 nmol/L 11,12-EET (n=6) with 0.5 mmol/L GTP and 1 mmol/L ATP, and a second successive 3-minute recording was obtained.
In some experiments, the concentration of ionized Ca2+ on the cytosolic side of inside-out patches was changed from 10-7 to 10-5 mol/L in the presence and absence of 11,12-EET (100 nmol/L), and the KCa channel current was recorded for 3 minutes at each Ca2+ concentration (n=5).
The excised inside-out patch mode was used to determine the effect of
GDP-ß-S (100 µmol/L) on 11,12-EETinduced activation of the
K+ channel (n=6). GDP-ß-S (100 µmol/L) and
11,12-EET were added to the GTP/ATP bath solution. The outside-out
patch mode was used to examine the effects of anti-GS
(n=7), anti-Gß
(n=8), and anti-Gi
(n=4) antibody
(New England Nuclear and Signal Transduction, Inc) and rabbit IgG
(n=4). Antibodies at concentrations of 10 or 100 nmol/L were added to
the pipette solution containing GTP/ATP.22
Western Blots of GS
Protein
The dissected coronary arteries were cut into very small
pieces and homogenized with a glass
homogenizer in ice-cold HEPES buffer containing 25
mmol/L sodium HEPES, 1 mmol/L EDTA, and 100 µmol/L
phenylmethylsulfonyl fluoride. The homogenate
containing 30 µg protein was incubated with 11,12-EET at
concentrations of 1 nmol/L to 10 µmol/L for 30 minutes and then
subjected to 12% SDS-PAGE at 200 V for 65 minutes
(Bio-Rad).23 The proteins were electrophoretically
transferred onto a nitrocellulose membrane. The membrane was washed and
probed with a 1:1000 dilution of a specific anti-GS
antibody (New England Nuclear). The ECL detection kit (Amersham) was
used to detect the specific GS
protein bands as
described by the manufacturer.
Statistics
Data are presented as mean±SEM. The significance of the
differences in mean values between and within multiple groups was
examined using an ANOVA for repeated measures, followed by a Duncan's
multiple-range test. Student's t test was used to evaluate
statistical significance of differences between two paired
observations. Single-channel conductances were fit by least-squares
linear regression or by using the Goldman-Hodgkin-Katz constant field
equation. A value of P<.05 was considered
statistically significant.
| Results |
|---|
|
|
|---|
0 mV. When the K+ concentration in the pipette was
reduced to 5.4 mmol/L, the reversal potential shifted in a manner
predicted by the Nernst equation for K+. This shift in
reversal potential in response to changes in K+ gradient
across the membrane suggests that this channel is selective for
K+ (Fig 1B
|
The effects of changes in the cytosolic Ca2+ concentration on the activity of this channel were examined using inside-out patches. When the Ca2+ concentration on the cytosolic side of the membrane patch was increased from 10-7 to 10-5 mol/L, the activity of K+ channel increased markedly. At a cytosolic Ca2+ concentration of 10-7 mol/L and membrane potential of +40 mV, the NPo of this K+ channel was 0.02±0.0012. When cytosolic Ca2+ concentration was increased to 10-6 and then to 10-5 mol/L, the NPo of this K+ channel was increased to 0.04±0.003 and 1.88±0.06, respectively.
TEA and IBX, inhibitors of the KCa channel,
were studied using the outside-out membrane patch mode.
Representative tracings depicting the results of these
experiments are presented in Fig 2A
. Addition of
TEA to the bath produced a concentration-dependent reversible
flickery-type blockade of the K+ channel. The mean unitary
current amplitude of this channel fell from 9.89 pA under control
conditions to 6.8, 4.7, and 2.24 pA after 0.1, 0.3, and 1 mmol/L
TEA, respectively, was added to bath (Fig 2B
). NPo of this
K+ channel was not altered by the addition of TEA. Fig 2C
presents representative tracings depicting the
effect of IBX on this K+ channel. IBX (100 nmol/L)
decreased NPo of the channel by 93% when added to the bath
(Fig 2D
), but it had no effect on the current amplitude of this
channel. These data are consistent with this being a
large-conductance KCa channel.
|
Effect of 11,12-EET on the Activity of the KCa Channel
in the Cell-Attached Patch Mode
Representative recordings of
single-channel K+ currents that were recorded in the
cell-attached mode before and after the addition of 11,12-EET to the
bath are presented in Fig 3A
. 11,12-EET caused a
concentration-dependent increase of the activity of the KCa
channel. 11,12-EET at concentrations of 1, 10, and 100 nmol/L produced
a 0.5- to 10-fold increase in NPo of this KCa
channel (Fig 3B
). A significant effect was seen even at the lowest
concentration of 11,12-EET studied (1 nmol/L) (P<.05). The
amplitude of these channels was unaltered by 11,12-EET even at the
highest concentration studied (100 nmol/L) (Fig 3C
). When cell membrane
potential was changed by adjusting the pipette potential from -20 to
-40 and then to -60 mV, the activity of the KCa channel
was significantly increased as described above, but the effects of
11,12-EET were not altered. 11,12-EET at a concentration of 100 nmol/L
produced an
10-fold increase in NPo of the
KCa channels in spite of changes in membrane potential from
20 to 60 mV. 12-HETE, a structural analogue of 11,12-EET, had no effect
on the activity of the KCa channel, and 20-HETE decreased
the activity of this KCa channel (P<.05) (Table 1
).
|
|
Effect of 11,12-EET on the Activity of the KCa Channel
in the Inside-out Patch Mode
In contrast to the marked effects of 11,12-EET (100 nmol/L) in
cell-attached patches, 11,12-EET had no effect on the activity of the
KCa channel when applied to the internal surface of
inside-out excised membrane patches (Table 2
). The
number of channel openings, mean open time, and the amplitude of these
KCa channels recorded from inside-out excised membrane
patches were not significantly altered when even a high concentration
of 11,12-EET (1 µmol/L) was applied to the internal surface of
the patch. NPo was 0.03±0.009 for control and 0.0267±0.01
with 11,12-EET. However, when 0.5 mmol/L GTP and 1 mmol/L ATP
were included in the bath solution, 11,12-EET produced a
concentration-dependent increase in the KCa activity (Fig 4A
). 11,12-EET increased the NPo of these
channels to an extent comparable to that in the cell-attached patch
mode and in comparable concentrations. The increase in the channel
activity was reversed by washing out the 11,12-EET (Fig 4B
). In
addition, addition of 0.5 mmol/L GTP alone also increased the
basal activity of the KCa channels by 15% and restored the
effect of 11,12-EET in these excised membrane patches to a level
comparable to that obtained in the cell-attached patches (Table 2
).
However, ATP alone had no effect on the basal activity of the
KCa channels, and 11,12-EET did not stimulate the
KCa channels in the presence of only ATP.
|
|
In the presence of GTP and ATP in the bath solution, the activity of the KCa channel was also increased in response to the increase in intracellular Ca2+ concentration. NPo of the KCa channel was 0.044±0.0013, 0.2995±0.04, and 1.88±0.02 at cytosolic Ca2+ concentrations of 10-7, 10-6, and 10-5 mol/L, respectively. When 11,12-EET was added to the bath, Ca2+-induced increase in NPo of the KCa channel was not altered. NPo of the KCa channel was 0.275±0.02, 0.832±0.12, and 2.61±0.2 at Ca2+ concentrations of 10-7, 10-6, and 10-5 mol/L, respectively. Calculated pCa50 in the presence of 11,12-EET averaged 2.3x10-6 mol/L, which was not significantly different from 2.6x10-6 mol/L in the absence of 11,12-EET in the bath solution.
Effect of GDP-ß-S on 11,12-EETInduced Activation of the
KCa Channel in the Inside-out Patch Mode
11,12-EET at a concentration of 100 nmol/L produced a 6-fold
increase in NPo of the KCa channels in the
presence of GTP/ATP. GDP-ß-S reduced NPo of the
KCa channels by 16% and completely abolished the effect of
11,12-EET on the activity of these channels (Fig 5A
).
|
Effect of Anti-GS
Antibody on 11,12-EETInduced
Increase in the KCa Channel Activity in the Outside-out
Patch Mode
Addition of 11,12-EET to the bath solution had no effect in the
excised outside-out patches in the absence of GTP and ATP in the
cytosolic solution: NPo was 0.15±0.02 in the control
condition and 0.167±0.023 with 100 nmol/L EET. When GTP and ATP were
included in the pipette solution, 11,12-EET increased markedly the
activity of these KCa channels. NPo of the
KCa channels was increased from 0.15±0.02 to 0.52±0.01,
but channel amplitude was not altered when 11,12-EET (100 nmol/L) was
added to the bath.
The effects of antibodies against GS
, Gi
,
or Gß
on the response of the KCa channel to 11,12-EET
were examined using this outside-out patch mode. When an antibody
against GS
at a concentration of 100 nmol/L was included
in the pipette solution, addition of 11,12-EET (100 nmol/L) to the bath
failed to alter the activity of the KCa channels. This
inhibitory effect of the anti-GS
antibody
was lost when the antibody concentration was decreased to 10 nmol/L or
when it was boiled for 10 minutes. When an anti-Gß
at a
concentration of 100 nmol/L, which completely blocks the stimulatory
effect of purified Gß
subunits on the KCa channels
(data not shown), was substituted for anti-GS
antibody
in the pipette solution, 11,12-EET still increased the activity of
the KCa channel to a comparable extent. Anti-Gi
antibody or rabbit IgG (100 nmol/L) had no effect on
11,12-EETinduced increase in the KCa channel activity.
Changes in NPo of the KCa channels induced by
11,12-EET in the presence of different antibodies in the pipette
solution are summarized in Fig 5B
. Only anti-GS
antibody
inhibited the increase in NPo of the KCa
channel induced by 11,12-EET.
Effect of Cholera Toxin on the Activity of the KCa
Channel
Cholera toxin at a concentration of 100 ng/mL increased the
activity of the KCa channels by 6-fold (Fig 6A
). In the presence of cholera toxin in the pipette
solution, 11,12-EET did not further increase the KCa
channel activity. NPo of the KCa channel was
0.1033±0.03 and 0.125±0.01 before and after the addition of 11,12-EET
in the bath solution, respectively (Fig 6B
). Cholera toxin did not
alter the current amplitude of the KCa channels (Fig 6C
).
|
Presence of GS
in Coronary Smooth
Muscle Cells
Based on molecular weight and reaction with a specific
anti-GS
antibody, there is a smooth muscle cell protein
that appears to be the
subunit of GS. Western blot of
the smooth muscle homogenate with anti-GS
antibody gave two protein bands of
52 and 45 kD. Similar results
were obtained with the GS
standard. 11,12-EET had no
effect on the electrophoretic migration of GS
.
| Discussion |
|---|
|
|
|---|
Recent studies have indicated that the vasodilatory response to EETs is associated with activation of the KCa channels in vascular smooth muscle cells isolated from cat cerebral arteries, rabbit portal vein, rat caudal arteries, and guinea pig aorta.10 14 In these studies, vascular smooth muscle cells were isolated from large arteries, and EET concentrations of 0.3 to 10 µmol/L were required to activate these channels. In the present study, using the cell-attached mode for single-channel recording, we found that the addition of 11,12-EET markedly enhanced the frequency of opening of the KCa channel in vascular smooth muscle cells in concentrations as low as 1 nmol/L. These data suggest that vascular smooth muscle cells from small coronary arteries are more sensitive to the effect of EET. In this regard, we have recently found that smaller vessels are more sensitive than large vessels to the vasorelaxant effect of EETs in isolated bovine coronary arterial rings.8 Why vascular smooth muscle cells isolated from small coronary arteries are more sensitive to 11,12-EET than those obtained from other species and vascular beds remains to be determined. This may reflect species differences or differences in vascular reactivity between vascular beds. Another possibility is that vascular smooth muscle cells from small resistance arteries like those studied in the present study are inherently more sensitive to the stimulatory effect of 11,12-EET on the KCa channels.
EETs are a series of metabolites of arachidonic acid synthesized by a cytochrome P450 epoxygenase.26 Although the regiospecific effect of the EETs was not determined in the present study, previous studies have demonstrated that the four regioisomers (5,6-EET, 8,9-EET, 11,12-EET, and 14,15-EET) have similar stimulatory effects on the activity of the KCa channels in vascular smooth muscle cells isolated from coronary and caudal arteries and aorta.8 14 As a result, we studied only 11,12-EET as a prototype. However, 12-HETE, a structural analogue of 11,12-EET, and 20-HETE, another cytochrome P450 metabolite of arachidonic acid, did not activate the KCa channels. In contrast, 20-HETE markedly reduced the activity of the KCa channels. These results indicate that the epoxide group of the EETs is essential for activation of the KCa channels.
To determine the mechanism by which 11,12-EET increases the activity of the KCa channels in smooth muscle cells, excised-membrane patches were used to examine the effects of 11,12-EET on the activity of the KCa channels. In contrast to the results obtained in cell-attached patch mode, 11,12-EET had no effect on the activity of the KCa channel when added to the cytoplasmic surface of excised inside-out or outside-out membrane patches. These results suggest that 11,12-EET does not directly act on the KCa channels but that some cytosolic component or second messenger system is required to alter the KCa channel activity. These results are consistent with previous reports of others.11 14
To further determine the cellular mechanism mediating the effect of 11,12-EET on the KCa channels, a series of experiments was performed using excised-membrane patches to examine whether the stimulatory effect of 11,12-EET on the KCa channel could be reconstituted. Surprisingly, when GTP alone or GTP and ATP were included in the cytosolic solution in inside-out or outside-out patches, the effect of 11,12-EET on the KCa channel activity was completely restored. This finding suggested that 11,12-EETinduced activation of the KCa channel is a GTP-dependent mechanism and may involve GTP binding proteins. By using the inside-out patch mode, the effect of a GTP binding protein inhibitor, GDP-ß-S, was examined on 11,12-EETinduced activation of the KCa channels. GDP-ß-S abolished the effect of 11,12-EET on the activity of the KCa channels. These findings further suggest that GTP and a GTP binding protein may contribute to 11,12-EET-induced activation of the KCa channel.
Since the GTP binding protein GS has been reported to
participate in the regulation of the KCa channel
activity,27 28 activation of GS may be
involved in the effect of 11,12-EET on the activity of the
KCa channel. To test this hypothesis, an
anti-GS
antibody was used to block GS
activity. Addition of an anti-GS
antibody to the
cytosolic solution blocked the effect of 11,12-EET on the activity of
the KCa channel. Since 11,12-EET was added to the external
cell membrane surface and the antibody to the cytosolic surface, it is
unlikely that blockade was due to a direct binding of 11,12-EET to the
antibody. In addition, the addition of an anti-Gi
antibody, anti-Gß
antibody, or rabbit IgG to the cytosolic
solution in the pipette had no effect on activation of the
KCa channels by 11,12-EET. Therefore, we conclude that a
specific blockade of GS abolishes the effect of 11,12-EET
on the activity of the KCa channels. Our findings support
the view that 11,12-EET activates a G protein, likely
GS, and, subsequently, the KCa channels. Since
only anti-GS
antibody blocked 11,12-EETinduced
activation of the KCa channels, the data imply that
GS
subunit is implicated in the effect of EET.
GS
may regulate the KCa channel via
two independent mechanisms.29 GS
can
activate adenylyl cyclase and promote cAMP accumulation,
resulting in PKA-dependent phosphorylation of the
channel or some proteins coupled to the channel.30 31 32
Alternatively, the GS
may have a direct action on the
channel or a closely associated protein.28 With respect to
the cAMP-PKAdependent mechanism, an increase in the
production of cAMP in response to 11,12-EET would be required.
However, in a recent study, we found that the vasodilator effect of
11,12-EET is not associated with an increase in the tissue content of
cAMP and cGMP.8 Furthermore, ATP would be required for PKA
to phosphorylate the channel. However, GTP alone can
restore the effect of 11,12-EET on the channel, so ATP is not required.
These data suggest that the cAMP-PKAdependent mechanism is not
involved. Therefore, the direct action of GS
on the
KCa channel is a likely mechanism for the effect of
11,12-EET. It has been reported that this membrane-delimited action of
GS
is a ubiquitous mechanism for regulating
K+ and Ca2+ channels.33 34
Although the significance of this action of GS
in the
gating of the KCa channels has not been characterized,
previous studies on the regulation of Ca2+ channels have
indicated that this membrane-delimited pathway for GS
is
far faster (<1 second) than the cytoplasmic cAMP pathway (
30
seconds).35 36 This membrane action of GS
has been shown to enhance the effect of agonists on ion
channels.37 38 However, the detailed coupling mechanisms
between GS
and the KCa channels for this
membrane-delimited pathway are not yet known. GS
might
act upon the channel proteins either directly, without requiring any
other membrane component, or indirectly, via intermediate
membrane-associated effectors. Further elucidation of the coupling
mechanism between GS
and the KCa channel in
coronary vascular smooth muscle will require functional
reconstitution of the interacting proteins in an artificial membrane
system. On the other hand, our results cannot exclude the possibility
that second messengers independent of cAMP and cGMP may participate in
the regulation of the activity of the KCa channel or
mediate the effect of 11,12-EET in the intact cells. This dual
modulation of the KCa channel through membrane-delimited
action of GS and some cytosolic signaling molecules has
been reported by others.28 29
There is evidence for a high-affinity binding site for
14(R),15(S)-EET in guinea pig mononuclear cell
membranes, suggesting that there may be EET receptors.39
Whether there is a specific receptor for 11,12-EET in the vascular
smooth muscle cell membrane remains to be determined. However, our
results raise questions about this possibility, since addition of
11,12-EET to the cytosolic solution in excised inside-out membrane
patches also increased the activity of the KCa channels in
the presence of ATP and GTP. It is, however, possible that 11,12-EET
could diffuse across the membrane and activate a receptor on
the external surface. Nevertheless, the findings that the effects of
11,12-EET on the activity of the KCa channels were
reversible in the excised patches but not in the cell-attached patches
suggest that 11,12-EET may activate GS
on the
cytosolic side of the membrane and that GS
may be a
target for the effect of lipid-soluble mediators that are slowly washed
out of intact cells. This direct effect of 11,12-EET on the
GS
activity independent of the receptors on the cell
surface may represent a unique mechanism mediating the action
of lipid-soluble mediators in vascular smooth muscle cells, by which
activation of GS
only produces a membrane-delimited
effect but does not stimulate the production of cAMP.
Alternatively, 11,12-EET may have a second action in intact cells that
is not observed in inside-out patches. This second action must be
slowly reversible. A recent study has indicated that EETs
stimulated the endogenous ADP-ribosylation of a 52-kD
protein in the liver.40 It remains to be determined
whether this endogenous ADP-ribosylation is
activated by 11,12-EET in coronary arterial
smooth muscle and what the relationship is between
EET-activated endogenous ADP-ribosylation and the
activity of GS.
In summary, 11,12-EET stimulates activation of the KCa channel in small bovine coronary arteries. This increase in the activity of the KCa channel appears to be due to activation of a GTP binding protein, probably GS. Activation of the KCa channel appears to contribute to the vasodilator effect of 11,12-EET by hyperpolarizing the vascular smooth muscle.8 EETs represent EDHFs.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
| Footnotes |
|---|
Received July 8, 1996; accepted March 27, 1997.
| References |
|---|
|
|
|---|
2. Rosolowsky M, Campbell WB. Synthesis of hydroxyeicosatetraenoic (HETE) and epoxyeicosatrienoic acid (EETs) by cultured bovine coronary artery endothelial cells. Biochim Biophys Acta. 1996;1299:267-277.[Medline] [Order article via Infotrieve]
3.
Pfister SL, Falck JR, Campbell WB. Enhanced
synthesis of epoxyeicosatrienoic acids by cholesterol-fed
rabbit aorta. Am J Physiol. 1991;261:H843-H852.
4.
Rosolowsky M, Falck JR, Willerson JT, Campbell
WB. Synthesis of lipoxygenase and
epoxygenase products of arachidonic
acid by normal and stenosed canine coronary arteries.
Circ Res. 1990;66:608-621.
5.
Rosolowsky M, Campbell WB. Role of PGI2 and
EETs in the relaxation of bovine coronary arteries to
arachidonic acid. Am J Physiol. 1993;264:H327-H335.
6.
Abraham NG, Pinto A, Mullane KM, Levere RD, Spokas
E. Presence of cytochrome p-450-dependent
monooxygenase in intimal cells of the dog aorta.
Hypertension. 1985;7:899-904.
7.
Pinto A, Abraham NG, Mullane KM.
Arachidonic acid-induced
endothelial-dependent relaxation of canine
coronary arteries: contribution of a cytochrome P-450 dependent
pathway. J Pharmacol Exp Ther. 1987;240:856-863.
8.
Campbell WB, Gebremedhin D, Pratt PF, Harder
DR. Identification of epoxyeicosatrienoic acids as
endothelium-derived hyperpolarizing factors.
Circ Res. 1996;78:415-423.
9.
Hecker M, Bara AT, Bauersachs J, Busse R.
Characterization of endothelium-derived hyperpolarizing
factor as a cytochrome P450-derived arachidonic acid
metabolite in mammals. J Physiol (Lond). 1994;481:407-414.
10. Gebremedhin D, Ma Y-H, Roman RJ, VanRollins M, Harder DR. Cellular mechanism of cerebral epoxyeicosatrienoic acid on cerebral arterial smooth muscle. Am J Physiol. 1992;263: H519-H525.
11. Zou A-P, Fleming JT, Falck JR, Jacobs ER, Gebremedhin D, Harder DR, Roman RJ. Regional and stereospecific effects of 11,12-epoxyeicosatrienoic acids on vascular tone and K+ channel activity in renal arterioles. Hypertension. 1994;24:382. Abstract.
12.
Carroll MA, Garcia MP, Falck JR, McGiff JC.
5,6-Epoxyeicosatrienoic acid, a novel arachidonic
metabolite: mechanism of vasoactivity in the rat. Circ
Res. 1990;67:1082-1088.
13.
Proctor KG, Falck JR, Capdevila J. Intestinal
vasodilation by epoxyeicosatrienoic acids: arachidonic
acid metabolites produced by a cytochrome P450
monooxygenase. Circ Res. 1987;60:50-59.
14. Hu S, Kim H. Activation of K+ channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid. Eur J Pharmacol. 1993;230:215-221.[Medline] [Order article via Infotrieve]
15. Fulton D, McGiff JC, Quilley J. Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney. Br J Pharmacol. 1992;107:722-725.[Medline] [Order article via Infotrieve]
16.
Pfister SL, Campbell WB.
Arachidonic acid and acetylcholine-induced relaxation
of rabbit aorta. Hypertension. 1992;20:682-689.
17.
Singer HA, Peach MJ.
Endothelium-dependent relaxation of rabbit aorta, I:
relaxation stimulated by arachidonic acid.
J Pharmacol Exp Ther. 1983;226:790-795.
18. Weston AH, Edwards G. Recent progress in potassium channel opener pharmacology. Biochem Pharmacol. 1992;43:47-54.[Medline] [Order article via Infotrieve]
19.
Van de Voorde J, Vanheel B, Leusen I.
Endothelium-dependent relaxation and
hyperpolarization in aorta from control and renal
hypertensive rats. Circ Res. 1992;70:1-8.
20. Hamill OP, Neher MR, Sakmann B. Improved patch clamp techniques for high-resolution current recording from cell and cell-free membrane patches. Pflugers Arch. 1981;391:85-100.[Medline] [Order article via Infotrieve]
21.
Godt RE. Calcium-activated tension of
skinned muscle fibers of the frog. J Gen
Physiol. 1974;63:722-739.
22.
Codina J, Yatani A, Grenet D, Brown AM, Birnbaumer L.
The
subunit of the GTP binding protein GK opens atrial
potassium channels. Science. 1987;236:442-445.
23. Laemmli UK. Cleavage of structural protein during assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.[Medline] [Order article via Infotrieve]
24.
Leblanc N, Wan X, Leung PM.
Physiological role of Ca2+
activated and voltage-dependent K+ currents in
rabbit coronary myocytes. Am J Physiol. 1994;266:C1523-C1537.
25. Taniguchi J, Furukawa K-I, Shigekawa M. Maxi K+ channels are stimulated by cyclic guanosine monophosphate-dependent protein kinase in canine coronary artery smooth muscle cells. Pflugers Arch. 1993;423:167-172.[Medline] [Order article via Infotrieve]
26. Falck JR, Schueler VJ, Jacobson HR, Siddhanta AK, Pramanik B, Capdevila J. Arachidonate epoxygenase: identification of epoxyeicosatrienoic acids in rabbit kidney J Lipid Res. 1987;28:840-846.[Abstract]
27. Kume H, Graziano MP, Kotlikoff MI. Stimulatory and inhibitory regulation of calcium-activated potassium channels by guanine nucleotide-binding proteins. Proc Natl Acad Sci U S A. 1992;89: 11051-11055.
28.
Scornik FS, Codina J, Birnbaumer L, Toro L.
Modulation of coronary smooth muscle KCa channels
by Gs
independent of phosphorylation by
protein kinase A. Am J Physiol. 1993;265:
H1460-H1465.
29.
Nelson MT, Quayle JM.
Physiological role and properties of potassium
channels in arterial smooth muscle. Am J
Physiol. 1995;268:C799-C822.
30.
Sadoshima J, Alkaike N, Tomoike H.
Ca-activated K+ channel in cultured smooth muscle
cells of rat aorta media. Am J Physiol. 1988;255:H410-H418.
31. Kume H, Takai A, Tokuno H, Tomita T. Regulation of Ca2+ dependent K+ channel activity in tracheal myocytes by phosphorylation. Nature. 1989;341:152-154.[Medline] [Order article via Infotrieve]
32.
Kume H, Kotlikoff MI. Muscarinic inhibition of
single KCa channels in smooth muscle cells by a
pertussis-sensitive G protein. Am J Physiol. 1991;261:C1204-C1209.
33.
McDonald TF, Pelzer S, Trautwein W, Pelzer DJ.
Regulation and modulation of calcium channels in cardiac, skeletal, and
smooth muscle cells. Physiol Rev. 1994;74:365-507.
34. Brown AM, Birnbaumer L. Ionic channels and their regulation by G protein subunits. Annu Rev Physiol. 1990;52:197-213.[Medline] [Order article via Infotrieve]
35. Kozlowski RZ, Twist VW, Brown AM, Powell T. Flash photolysis of intracellular caged GTP gamma S increases L-typed Ca2+ currents in cardiac myocytes. Am J Physiol. 1991;216:H1665-H1670.
36.
Yatani A, Brown AM. Rapid beta-adrenergic
modulation of cardiac calcium channel currents by a fast G protein
pathway. Science. 1989;245:71-74.
37. Cavalie A, Allen TJ, Trautwein W. Role of the GTP-binding protein GS in the beta-adrenergic modulation of cardiac Ca channels. Pflugers Arch. 1991;419:433-443.[Medline] [Order article via Infotrieve]
38.
Pelzer S, Shuba YM, Asai T, Codina J, Birnbaumer L,
McDonald TF, Pelzer D. Membrane-delimited stimulation of heart
cell calcium current by beta-adrenergic signal-transducing
GS protein. Am J Physiol. 1990;259:H264-H267.
39. Wong PY, Lin KT, Yan YT, Ahern D, Iles J, Shen SY, Bhatt RK, Falck JR. 14(R),15(S)-Epoxyeicosatrienoic acid (14(R),15(S)- EET) receptor in guinea pig mononuclear cell membranes. J Lipid Mediat Cell Signal. 1993;6:199-208.
40. Seki K, Hirai A, Noda M, Tamura Y, Kato I, Yoshida S. Epoxyeicosatrienoic acid stimulates ADP-ribosylation of a 52 KDa protein in rat liver cytosol. Biochem J. 1992;281:185-190.
This article has been cited by other articles:
![]() |
Y. Chen, J. R. Falck, V. R. Tuniki, and W. B. Campbell 20-125Iodo-14,15-Epoxyeicosa-5(Z)-enoic Acid: a High-Affinity Radioligand Used to Characterize the Epoxyeicosatrienoic Acid Antagonist Binding Site J. Pharmacol. Exp. Ther., December 1, 2009; 331(3): 1137 - 1145. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ellis, K. Goto, D. J. Chaston, T. D. Brackenbury, K. R. Meaney, J. R. Falck, R. J. H. Wojcikiewicz, and C. E. Hill Enalapril Treatment Alters the Contribution of Epoxyeicosatrienoic Acids but Not Gap Junctions to Endothelium-Derived Hyperpolarizing Factor Activity in Mesenteric Arteries of Spontaneously Hypertensive Rats J. Pharmacol. Exp. Ther., August 1, 2009; 330(2): 413 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Buczynski, D. S. Dumlao, and E. A. Dennis Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology J. Lipid Res., June 1, 2009; 50(6): 1015 - 1038. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Hoffmann, I. H. Lambert, and S. F. Pedersen Physiology of Cell Volume Regulation in Vertebrates Physiol Rev, January 1, 2009; 89(1): 193 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Behm, A. Ogbonna, C. Wu, C. L. Burns-Kurtis, and S. A. Douglas Epoxyeicosatrienoic Acids Function as Selective, Endogenous Antagonists of Native Thromboxane Receptors: Identification of a Novel Mechanism of Vasodilation J. Pharmacol. Exp. Ther., January 1, 2009; 328(1): 231 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Loot, R. Popp, B. Fisslthaler, J. Vriens, B. Nilius, and I. Fleming Role of cytochrome P450-dependent transient receptor potential V4 activation in flow-induced vasodilatation Cardiovasc Res, December 1, 2008; 80(3): 445 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. H. Mnjoyan, D. Doan, J. L. Brandon, K. Felix, C. L. Sitter, A. A. Rege, T. A. Brock, and K. Fujise The critical role of the intrinsic VSMC proliferation and death programs in injury-induced neointimal hyperplasia Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2276 - H2284. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yang, V. R. Tuniki, S. Anjaiah, J. R. Falck, C. J. Hillard, and W. B. Campbell Characterization of Epoxyeicosatrienoic Acid Binding Site in U937 Membranes Using a Novel Radiolabeled Agonist, 20-125I-14,15-Epoxyeicosa-8(Z)-Enoic Acid J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1019 - 1027. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Larsen, D. X. Zhang, and D. D. Gutterman Epoxyeicosatrienoic Acids, TRP Channels, and Intracellular Ca2+ in the Vasculature: An Endothelium-Derived Endothelium-Hyperpolarizing Factor? Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2496 - 2498. [Full Text] [PDF] |
||||
![]() |
Q. Ke, Y.-F. Xiao, J. A. Bradbury, J. P. Graves, L. M. DeGraff, J. M. Seubert, and D. C. Zeldin Electrophysiological Properties of Cardiomyocytes Isolated from CYP2J2 Transgenic Mice Mol. Pharmacol., October 1, 2007; 72(4): 1063 - 1073. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-L. Dong, Y. Zhang, D.-H. Lin, J. Chen, S. Patschan, M. S. Goligorsky, A. Nasjletti, B.-F. Yang, and W.-H. Wang Carbon Monoxide Stimulates the Ca2+ Activated Big Conductance K Channels in Cultured Human Endothelial Cells Hypertension, October 1, 2007; 50(4): 643 - 651. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yang, B. B. Holmes, V. R. Gopal, R. V. K. Kishore, B. Sangras, X.-Y. Yi, J. R. Falck, and W. B. Campbell Characterization of 14,15-Epoxyeicosatrienoyl-Sulfonamides as 14,15-Epoxyeicosatrienoic Acid Agonists: Use for Studies of Metabolism and Ligand Binding J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1023 - 1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. DeLozier, G. E. Kissling, S. J. Coulter, D. Dai, J. F. Foley, J. A. Bradbury, E. Murphy, C. Steenbergen, D. C. Zeldin, and J. A. Goldstein Detection of Human CYP2C8, CYP2C9, and CYP2J2 in Cardiovascular Tissues Drug Metab. Dispos., April 1, 2007; 35(4): 682 - 688. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Spector and A. W. Norris Action of epoxyeicosatrienoic acids on cellular function Am J Physiol Cell Physiol, March 1, 2007; 292(3): C996 - C1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Campbell and J. R. Falck Arachidonic Acid Metabolites as Endothelium-Derived Hyperpolarizing Factors Hypertension, March 1, 2007; 49(3): 590 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xu, N. Li, Y. He, V. Timofeyev, L. Lu, H.-J. Tsai, I.-H. Kim, D. Tuteja, R. K. P. Mateo, A. Singapuri, et al. Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors PNAS, December 5, 2006; 103(49): 18733 - 18738. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Dong, A. Smith, M. Hovaida, and J. Y. Chow Role of Ca2+-activated K+ channels in duodenal mucosal ion transport and bicarbonate secretion Am J Physiol Gastrointest Liver Physiol, December 1, 2006; 291(6): G1120 - G1128. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dhanasekaran, R. Al-Saghir, B. Lopez, D. Zhu, D. D. Gutterman, E. R. Jacobs, and M. Medhora Protective effects of epoxyeicosatrienoic acids on human endothelial cells from the pulmonary and coronary vasculature Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H517 - H531. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Inoue, L. J. Jensen, J. Shi, H. Morita, M. Nishida, A. Honda, and Y. Ito Transient Receptor Potential Channels in Cardiovascular Function and Disease Circ. Res., July 21, 2006; 99(2): 119 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Carroll, A. B. Doumad, J. Li, M. K. Cheng, J. R. Falck, and J. C. McGiff Adenosine2A receptor vasodilation of rat preglomerular microvessels is mediated by EETs that activate the cAMP/PKA pathway Am J Physiol Renal Physiol, July 1, 2006; 291(1): F155 - F161. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Feletou and P. M. Vanhoutte Endothelium-Derived Hyperpolarizing Factor: Where Are We Now? Arterioscler Thromb Vasc Biol, June 1, 2006; 26(6): 1215 - 1225. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ye, W. Zhou, T. Lu, S. G. Jagadeesh, J. R. Falck, and H.-C. Lee Mechanism of rat mesenteric arterial KATP channel activation by 14,15-epoxyeicosatrienoic acid Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1326 - H1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Fleming and R. Busse Endothelium-Derived Epoxyeicosatrienoic Acids and Vascular Function Hypertension, April 1, 2006; 47(4): 629 - 633. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Larsen, H. Miura, O. A. Hatoum, W. B. Campbell, B. D. Hammock, D. C. Zeldin, J. R. Falck, and D. D. Gutterman Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BKCa channels: implications for soluble epoxide hydrolase inhibition Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H491 - H499. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Campbell, B. B. Holmes, J. R. Falck, J. H. Capdevila, and K. M. Gauthier Regulation of potassium channels in coronary smooth muscle by adenoviral expression of cytochrome P-450 epoxygenase Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H64 - H71. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Earley, T. J. Heppner, M. T. Nelson, and J. E. Brayden TRPV4 Forms a Novel Ca2+ Signaling Complex With Ryanodine Receptors and BKCa Channels Circ. Res., December 9, 2005; 97(12): 1270 - 1279. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lu, X.-L. Wang, T. He, W. Zhou, T. L. Kaduce, Z. S. Katusic, A. A. Spector, and H.-C. Lee Impaired Arachidonic Acid-Mediated Activation of Large-Conductance Ca2+-Activated K+ Channels in Coronary Arterial Smooth Muscle Cells in Zucker Diabetic Fatty Rats Diabetes, July 1, 2005; 54(7): 2155 - 2163. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lu, M.-P. Hong, and H.-C. Lee Molecular Determinants of Cardiac KATP Channel Activation by Epoxyeicosatrienoic Acids J. Biol. Chem., May 13, 2005; 280(19): 19097 - 19104. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Gauthier, E. M. Edwards, J. R. Falck, D. S. Reddy, and W. B. Campbell 14,15-Epoxyeicosatrienoic Acid Represents a Transferable Endothelium-Dependent Relaxing Factor in Bovine Coronary Arteries Hypertension, April 1, 2005; 45(4): 666 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Gauthier, D. V. Baewer, S. Hittner, C. J. Hillard, K. Nithipatikom, D. S. Reddy, J. R. Falck, and W. B. Campbell Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1344 - H1351. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Pomposiello, J. Quilley, M. A. Carroll, J. R. Falck, and J. C. McGiff 5,6-Epoxyeicosatrienoic Acid Mediates the Enhanced Renal Vasodilation to Arachidonic Acid in the SHR Hypertension, October 1, 2003; 42(4): 548 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Gauthier, S. G. Jagadeesh, J. R. Falck, and W. B. Campbell 14,15-Epoxyeicosa-5(Z)-Enoic-mSI: A 14,15- and 5,6-EET Antagonist in Bovine Coronary Arteries Hypertension, October 1, 2003; 42(4): 555 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Falck, U. M. Krishna, Y. K. Reddy, P. S. Kumar, K. M. Reddy, S. B. Hittner, C. Deeter, K. K. Sharma, K. M. Gauthier, and W. B. Campbell Comparison of vasodilatory properties of 14,15-EET analogs: structural requirements for dilation Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H337 - H349. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ye, D. Zhang, C. Oltman, K. Dellsperger, H.-C. Lee, and M. VanRollins Cytochrome P-450 Epoxygenase Metabolites of Docosahexaenoate Potently Dilate Coronary Arterioles by Activating Large-Conductance Calcium-Activated Potassium Channels J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 768 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lu, M. VanRollins, and H.-C. Lee Stereospecific Activation of Cardiac ATP-Sensitive K+ Channels by Epoxyeicosatrienoic Acids: A Structural Determinant Study Mol. Pharmacol., November 1, 2002; 62(5): 1076 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fuloria, T. K. Smith, and J. L. Aschner Role of 5,6-epoxyeicosatrienoic acid in the regulation of newborn piglet pulmonary vascular tone Am J Physiol Lung Cell Mol Physiol, August 1, 2002; 283(2): L383 - L389. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Gauthier, C. Deeter, U. M. Krishna, Y. K. Reddy, M. Bondlela, J.R. Falck, and W. B. Campbell 14,15-Epoxyeicosa-5(Z)-enoic Acid: A Selective Epoxyeicosatrienoic Acid Antagonist That Inhibits Endothelium-Dependent Hyperpolarization and Relaxation in Coronary Arteries Circ. Res., May 17, 2002; 90(9): 1028 - 1036. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Potente, U. R. Michaelis, B. Fisslthaler, R. Busse, and I. Fleming Cytochrome P450 2C9-induced Endothelial Cell Proliferation Involves Induction of Mitogen-activated Protein (MAP) Kinase Phosphatase-1, Inhibition of the c-Jun N-terminal Kinase, and Up-regulation of Cyclin D1 J. Biol. Chem., May 3, 2002; 277(18): 15671 - 15676. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-K. Chen, J. Capdevila, and R. C. Harris Heparin-binding EGF-like growth factor mediates the biological effects of P450 arachidonate epoxygenase metabolites in epithelial cells PNAS, April 30, 2002; 99(9): 6029 - 6034. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lauterbach, E. Barbosa-Sicard, M.-H. Wang, H. Honeck, E. Kargel, J. Theuer, M. L. Schwartzman, H. Haller, F. C. Luft, M. Gollasch, et al. Cytochrome P450-Dependent Eicosapentaenoic Acid Metabolites Are Novel BK Channel Activators Hypertension, February 1, 2002; 39(2): 609 - 613. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Roman P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function Physiol Rev, January 1, 2002; 82(1): 131 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zou, Q. Yang, A. P.C. Yim, and G.-W. He Epoxyeicosatrienoic acids (EET11,12) may partially restore endothelium-derived hyperpolarizing factor-mediated function in coronary microarteries Ann. Thorac. Surg., December 1, 2001; 72(6): 1970 - 1976. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Fleming Cytochrome P450 and Vascular Homeostasis Circ. Res., October 26, 2001; 89(9): 753 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Chilian and R. Koshida EDHF and NO: Different Pathways for Production--Similar Actions Circ. Res., October 12, 2001; 89(8): 648 - 649. [Full Text] [PDF] |
||||
![]() |
A. W. Miller, C. Dimitropoulou, G. Han, R. E. White, D. W. Busija, and G. O. Carrier Epoxyeicosatrienoic acid-induced relaxation is impaired in insulin resistance Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1524 - H1531. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lu, P. V G Katakam, M. VanRollins, N. L Weintraub, A. A Spector, and H.-C. Lee Dihydroxyeicosatrienoic acids are potent activators of Ca2+-activated K+ channels in isolated rat coronary arterial myocytes J. Physiol., August 1, 2001; 534(3): 651 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, C. L. Oltman, T. Lu, H.-C. Lee, K. C. Dellsperger, and M. VanRollins EET homologs potently dilate coronary microvessels and activate BKCa channels Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2430 - H2440. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Benoit, B. Renaudon, D. Salvail, and E. Rousseau EETs relax airway smooth muscle via an EpDHF effect: BKCa channel activation and hyperpolarization Am J Physiol Lung Cell Mol Physiol, May 1, 2001; 280(5): L965 - L973. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Pratt, P. Li, C. J. Hillard, J. Kurian, and W. B. Campbell Endothelium-independent, ouabain-sensitive relaxation of bovine coronary arteries by EETs Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1113 - H1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Pomposiello, M. A. Carroll, J. R. Falck, and J. C. McGiff Epoxyeicosatrienoic Acid-Mediated Renal Vasodilation to Arachidonic Acid Is Enhanced in SHR Hypertension, March 1, 2001; 37(3): 887 - 893. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Zink, C. L. Oltman, T. Lu, P. V. G. Katakam, T. L. Kaduce, H.-C. Lee, K. C. Dellsperger, A. A. Spector, P. R. Myers, and N. L. Weintraub 12-Lipoxygenase in porcine coronary microcirculation: implications for coronary vasoregulation Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H693 - H704. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gu, Y. Wei, H. Jiang, M. Balazy, and W. Wang Role of 20-HETE in mediating the effect of dietary K intake on the apical K channels in the mTAL Am J Physiol Renal Physiol, February 1, 2001; 280(2): F223 - F230. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fukao, H. S. Mason, J. L. Kenyon, B. Horowitz, and K. D. Keef Regulation of BKca Channels Expressed in Human Embryonic Kidney 293 Cells by Epoxyeicosatrienoic Acid Mol. Pharmacol., January 1, 2001; 59(1): 16 - 23. [Abstract] [Full Text] |
||||
![]() |
D. G. Welsh and S. S. Segal Role of EDHF in conduction of vasodilation along hamster cheek pouch arterioles in vivo Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H1832 - H1839. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Capdevila, J. R. Falck, and R. C. Harris Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase J. Lipid Res., February 1, 2000; 41(2): 163 - 181. [Abstract] [Full Text] |
||||
![]() |
S.-S. BOLZ, B. FISSLTHALER, S. PIEPERHOFF, C. DE WIT, I. FLEMING, R. BUSSE, and U. POHL Antisense oligonucleotides against cytochrome P450 2C8 attenuate EDHF-mediated Ca2+ changes and dilation in isolated resistance arteries FASEB J, February 1, 2000; 14(2): 255 - 260. [Abstract] [Full Text] |
||||
![]() |
J. E. HUNGERFORD, W. C. SESSA, and S. S. SEGAL Vasomotor control in arterioles of the mouse cremaster muscle FASEB J, January 1, 2000; 14(1): 197 - 207. [Abstract] [Full Text] |
||||
![]() |
N. L. Weintraub, X. Fang, T. L. Kaduce, M. VanRollins, P. Chatterjee, and A. A. Spector Epoxide hydrolases regulate epoxyeicosatrienoic acid incorporation into coronary endothelial phospholipids Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H2098 - H2108. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. McGiff and J. Quilley 20-HETE and the kidney: resolution of old problems and new beginnings Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1999; 277(3): R607 - R623. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Frieden, M Sollini, and J-L Beny Substance P and bradykinin activate different types of KCa currents to hyperpolarize cultured porcine coronary artery endothelial cells J. Physiol., September 1, 1999; 519(2): 361 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-L. Li, C.-L. Chen, R. Bortell, and W. B. Campbell 11,12-Epoxyeicosatrienoic Acid Stimulates Endogenous Mono-ADP-Ribosylation in Bovine Coronary Arterial Smooth Muscle Circ. Res., August 20, 1999; 85(4): 349 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-C. Lee, T. Lu, N. L Weintraub, M. VanRollins, A. A Spector, and E. F Shibata Effects of epoxyeicosatrienoic acids on the cardiac sodium channels in isolated rat ventricular myocytes J. Physiol., August 15, 1999; 519(1): 153 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-L. Li, D. X. Zhang, A.-P. Zou, and W. B. Campbell Effect of Ceramide on KCa Channel Activity and Vascular Tone in Coronary Arteries Hypertension, June 1, 1999; 33(6): 1441 - 1446. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schubert, T. Noack, and V. N. Serebryakov Protein kinase C reduces the KCa current of rat tail artery smooth muscle cells Am J Physiol Cell Physiol, March 1, 1999; 276(3): C648 - C658. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-K. Chen, D.-W. Wang, J. R. Falck, J. Capdevila, and a. R. C. Harris Transfection of an Active Cytochrome P450 Arachidonic Acid Epoxygenase Indicates That 14,15-Epoxyeicosatrienoic Acid Functions as an Intracellular Second Messenger in Response to Epidermal Growth Factor J. Biol. Chem., February 19, 1999; 274(8): 4764 - 4769. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R. Hutcheson, A. T. Chaytor, W. H. Evans, and T. M. Griffith Nitric Oxide–Independent Relaxations to Acetylcholine and A23187 Involve Different Routes of Heterocellular Communication : Role of Gap Junctions and Phospholipase A2 Circ. Res., January 22, 1999; 84(1): 53 - 63. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Imig, E. W. Inscho, P. C. Deichmann, K. M. Reddy, and J. R. Falck Afferent Arteriolar Vasodilation to the Sulfonimide Analog of 11,12-Epoxyeicosatrienoic Acid Involves Protein Kinase A Hypertension, January 1, 1999; 33(1): 408 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-K. Chen, J. R. Falck, K. M. Reddy, J. Capdevila, and R. C. Harris Epoxyeicosatrienoic Acids and Their Sulfonimide Derivatives Stimulate Tyrosine Phosphorylation and Induce Mitogenesis in Renal Epithelial Cells J. Biol. Chem., October 30, 1998; 273(44): 29254 - 29261. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dumoulin, D. Salvail, S. B. Gaudreault, A. Cadieux, and E. Rousseau Epoxyeicosatrienoic acids relax airway smooth muscles and directly activate reconstituted KCa channels Am J Physiol Lung Cell Mol Physiol, September 1, 1998; 275(3): L423 - L431. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Salvail, M. Dumoulin, and E. Rousseau Direct modulation of tracheal Cl--channel activity by 5,6- and 11,12-EET Am J Physiol Lung Cell Mol Physiol, September 1, 1998; 275(3): L432 - L441. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-L. Li, A.-P. Zou, and W. B. Campbell Regulation of KCa-channel activity by cyclic ADP-ribose and ADP-ribose in coronary arterial smooth muscle Am J Physiol Heart Circ Physiol, September 1, 1998; 275(3): H1002 - H1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bylund, T. Kunz, K. Valmsen, and E. H. Oliw Cytochromes P450 with Bisallylic Hydroxylation Activity on Arachidonic and Linoleic Acids Studied with Human Recombinant Enzymes and with Human and Rat Liver Microsomes J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 51 - 60. [Abstract] [Full Text] |
||||
![]() |
P.-L. Li, M.-W. Jin, and W. B. Campbell Effect of Selective Inhibition of Soluble Guanylyl Cyclase on the KCa Channel Activity in Coronary Artery Smooth Muscle Hypertension, January 1, 1998; 31(1): 303 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Campbell, C. Deeter, K. M. Gauthier, R. H. Ingraham, J. R. Falck, and P.-L. Li 14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of KCa channels Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1656 - H1664. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-L. Li, D. X. Zhang, Z.-D. Ge, and W. B. Campbell Role of ADP-ribose in 11,12-EET-induced activation of KCa channels in coronary arterial smooth muscle cells Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1229 - H1236. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vequaud and E. Thorin Endothelial G Protein {beta}-Subunits Trigger Nitric Oxide- but not Endothelium-Derived Hyperpolarizing Factor-Dependent Dilation in Rabbit Resistance Arteries Circ. Res., October 12, 2001; 89(8): 716 - 722. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |